Dog Cloning: Complete Guide
Photo: Photo by Sudhir Sangwan via Pexels – Pexels License
The History of Dog Cloning
The story of dog cloning begins not with dogs but with sheep. In 1996, Ian Wilmut and colleagues at the Roslin Institute in Scotland announced Dolly, the first mammal cloned from an adult somatic cell. Dolly’s birth proved that the DNA in a fully differentiated adult cell could be reprogrammed to direct the development of a complete new organism – a finding that fundamentally changed what was thought possible in developmental biology. The technique used – somatic cell nuclear transfer (SCNT) – became the template for all subsequent mammalian cloning work.
Dogs presented a particularly challenging target for cloners. Unlike mice, cattle, or pigs, dogs ovulate primary oocytes – eggs that have not yet completed their first meiotic division – requiring them to complete maturation in vivo (inside the fallopian tube) before they can be used in nuclear transfer. This made egg collection far more difficult than in other mammals, where eggs could be harvested from the ovaries and matured in laboratory culture. Korean researchers, particularly the team at Seoul National University led by Hwang Woo-suk, overcame these obstacles by surgically collecting naturally ovulated eggs from donor dogs.
Snuppy: The First Cloned Dog
In 2005, the Seoul National University team announced the successful birth of Snuppy (an acronym for Seoul National University puppy), an Afghan Hound cloned from an adult male Afghan Hound. Snuppy was the result of 1,095 embryo transfers into 123 surrogate females, of which three became pregnant, two delivered, one died shortly after birth from pneumonia, and Snuppy survived. The efficiency – one surviving clone from over a thousand transferred embryos – illustrated both the achievement and the challenge. Snuppy lived until 2015, dying of cancer at age 10; in 2017, four clones were made from Snuppy’s cells, continuing the research lineage.
The announcement was partly overshadowed by revelations that Hwang’s concurrent claims about human embryonic stem cell research were fraudulent. However, independent verification confirmed that Snuppy was indeed a genuine canine somatic cell nuclear transfer clone and that the dog cloning work was legitimate. This distinction matters: the dog cloning science was real even as other aspects of the lab’s published work were not.
Commercial Cloning Emerges
Following Snuppy’s birth, the possibility of commercial pet cloning attracted both serious scientific interest and significant investment. South Korea’s RNL Bio (later merged into other entities) and Sooam Biotech, founded by Hwang Woo-suk after his departure from Seoul National University, developed commercial dog cloning services. Sooam was the primary commercial provider through the 2010s, charging approximately $100,000 per clone and completing hundreds of orders for clients worldwide.
In the United States, ViaGen Pets launched dog cloning services at approximately $50,000 per dog, making the U.S. market accessible without international travel. ViaGen offers both cloning and genetic preservation (cell banking) services, and its U.S.-based operation resolved logistical concerns some clients had about shipping biological material internationally.
The Science of Dog Cloning: What It Actually Produces
Understanding what cloning produces – and what it does not – requires clarity about what DNA actually controls in the development of an individual dog. This is the area where popular misconceptions about cloning are most damaging to realistic expectations.
Nuclear DNA vs. the Whole Dog
Cloning by somatic cell nuclear transfer produces an animal with nuclear DNA identical to the original. The clone will have the same genetic sequence in its cell nuclei as the donor dog. This means the clone will be the same breed, will carry the same coat color genes, the same structural genes determining body proportions, and the same disease susceptibilities encoded in the nuclear genome.
What cloning does not replicate is everything that makes a dog its unique self beyond its nuclear DNA sequence. This includes:
- Mitochondrial DNA: The mitochondria in the clone’s cells come from the egg donor’s cytoplasm, not the original dog. The clone has different mitochondrial DNA from its genetic source.
- Epigenetics: The pattern of gene expression – which genes are switched on or off, and at what levels – is not encoded in the DNA sequence itself. Epigenetic patterns are influenced by environment, diet, stress, and development history. The clone will develop its own epigenetic profile independent of the original dog’s.
- The microbiome: The original dog’s gut flora, skin bacteria, and other microbial communities are not transmitted through cloning. The clone will develop its own microbiome based on its own environment and exposures.
- Developmental variation: Even genetically identical twins raised together show physical differences – different coat patterns (especially in spotted breeds), minor anatomical variations, and immunological differences. Identical twins are natural clones; their differences illustrate the limits of genetic identity as a predictor of physical identity.
- Personality and memories: A dog’s personality emerges from the interaction of genetic predispositions with developmental experience, socialization, training, and accumulated life history. The clone is born with no knowledge of the original dog, no shared memories, no learned behaviors. It will have its own personality shaped by its own life.
Coat Patterns in Clones
One of the clearest demonstrations of the gap between genetic identity and physical identity is coat pattern in dogs with variable markings. In breeds where spot patterns, merle markings, or patch distributions are not fully predetermined by genetics, clones routinely show different coat patterns than the original. This is because the migration and distribution of pigment-producing melanocyte cells during fetal development involves stochastic (random) processes that are not deterministic from the DNA sequence. The clone will have the same genes for color type and base coloring, but the exact distribution of that color can differ.
Success Rates and Multiple Surrogates
Commercial dog cloning involves significantly more biological complexity than the client typically appreciates. To produce one viable clone puppy, a cloning company typically needs to: harvest eggs from multiple donor females, create dozens to hundreds of cloned embryos, implant embryos in multiple surrogate females, and manage multiple pregnancies over several months. The surrogate females used in this process are working animals whose welfare and reproductive health are directly consumed by the service. Modern commercial providers do not publish precise per-procedure success rates, but industry-informed estimates suggest that between 20 and 30 surrogate procedures may be involved in a single successful commercial cloning order.
Who Clones Their Dogs and Why
The commercial dog cloning market is small but distinct. Most clients fall into several recognizable categories: grieving pet owners who have lost an exceptionally close companion animal and feel that the relationship was irreplaceable; owners of working dogs – police K9s, service dogs, championship competition dogs – whose specific trained capabilities took years to develop and who hope genetic similarity will accelerate training the next generation; and breeders or enthusiasts of rare breeds who see genetic banking and potential cloning as a preservation strategy.
Famous Cloned Dogs
Several high-profile cloning cases have attracted media attention. Barbra Streisand disclosed in a 2018 interview that she had cloned her late Coton de Tulear, Samantha, producing two puppies named Miss Violet and Miss Scarlett from Samantha’s cells. Streisand’s account was candid about the emotional experience, noting that while the dogs look very similar to Samantha, their personalities are distinctly their own – an honest acknowledgment of the limits of cloning that helped public understanding of the technology.
Various South Korean police and military dog programs have explored cloning as a way to replicate dogs with exceptional detection abilities, recognizing that elite working dogs represent substantial training investments. The Sooam Biotech facility worked with Korean authorities on such projects in the 2010s.
Cell Preservation as a Lower-Commitment Option
Many dog owners who are uncertain about cloning but want to preserve the option choose cell banking – the cryopreservation of tissue samples from a living dog – as a lower-commitment first step. ViaGen Pets offers preservation for approximately $1,600 with an annual storage fee. Preserved cells can remain viable in liquid nitrogen storage for decades, allowing owners to decide whether to proceed with cloning at a later date, potentially when costs change or the science improves. For owners of very young dogs with exceptional working ability or personal significance, cell banking offers a form of genetic insurance without the immediate cost and ethical weight of cloning.
Ethical Considerations in Dog Cloning
Dog cloning raises substantive ethical questions that deserve serious consideration beyond the simple fact that the technology exists and is legal in most jurisdictions. These questions operate at several levels: the welfare of the animals used in the cloning process, the appropriate use of very significant financial resources, and broader concerns about the commodification of animals and the psychology of grief.
Animal Welfare and the Cloning Process
The primary animal welfare concern in commercial dog cloning is the number of animals involved in producing each clone. Egg donor dogs undergo repeated hormonal stimulation and surgical egg retrieval. Surrogate dogs carry pregnancies and give birth to puppies that are then given to the client, with the surrogate’s role in the process complete. The surrogate and egg donor dogs are working reproductive animals whose entire purpose in the commercial structure is to service the cloning procedure.
Reputable providers represent these animals as well cared for and not subjected to welfare-compromising conditions. Critics argue that the commercial structure necessarily incentivizes maximizing reproductive output from these animals in ways that may not serve their welfare interests, and that the sheer number of procedures required per successful clone (with failed pregnancies, embryo losses, and unsuccessful transfers along the way) represents a significant aggregate welfare cost.
The Grief Context
Most commercial dog cloning orders arise in the context of grief – the loss of a beloved companion animal. Ethicists and veterinary psychologists have raised concerns about whether cloning represents a healthy or unhealthy grief response. The argument is not that grief itself is wrong, but that cloning a dog with the expectation of replacing the lost animal sets up an expectation that cannot be fulfilled, since the clone is a new individual and not the continuation of the old one. The moment of meeting a clone and finding a different personality than expected – which is virtually guaranteed – can intensify grief rather than resolve it, producing a second loss-like experience superimposed on the original bereavement.
At the same time, others argue that understanding these limits, cloning can be a meaningful way to maintain a genetic connection to a loved animal, to preserve a distinctive bloodline, or simply to have a dog of the same breed with the same physical appearance – and that adults capable of informed consent deserve the autonomy to make this choice for themselves.
Financial Opportunity Cost
$50,000 to $100,000 is a very large sum to spend on producing a single puppy. Animal welfare advocates note that this sum could fund the rescue, medical care, and rehoming of dozens to hundreds of dogs in need. This is an opportunity cost argument, not a legal or rights-based one, and individuals may weigh it differently based on their personal values and relationship with money. It remains a consideration worth surfacing for anyone genuinely weighing the decision.
Alternatives to Cloning
Genetic Preservation (Cell Banking)
As noted above, cell banking preserves the option to clone without requiring an immediate decision. For owners of young dogs with exceptional qualities, this is the most pragmatic approach: bank the cells now for a fraction of the cloning cost, and decide later whether to proceed. Preserved cell lines can remain viable in liquid nitrogen for decades without degradation.
Breed Continuation
For owners whose primary motivation is breed-related – the specific physical type, energy level, and general behavioral tendencies of their dog – the same breed from a quality breeder will share the majority of the genetic characteristics they valued. A new dog from the same breed and ideally similar breeding lines will have the same constitutional qualities that defined the original dog’s type, even without the identical DNA. This is the approach most recommended by grief specialists as the most emotionally healthy path for most owners.
DNA Testing and Genetic Profiles
Services like Embark and Wisdom Panel provide comprehensive genetic profiles of a dog that can be preserved indefinitely at very low cost. While these cannot be used to clone a dog, they create a permanent genetic record that captures breed composition, health markers, and genetic traits. For owners who simply want to preserve knowledge of their dog’s genetic makeup, this is an affordable and immediate option.
Working with What Was Achieved
For owners of exceptional working dogs, the most pragmatic approach is often to preserve offspring from the dog (if breeding is possible before loss) or to meticulously document and record the specific training achievements, so that those achievements can be replicated through training with a new dog. A well-trained police dog’s exceptional nose work cannot be cloned – but the training protocol that produced those skills can be applied to the next generation.